Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Rectal microbicides: Clinically relevant approach to the design of rectal specific placebo formulations

Wang, L and Schnaare, RL and Dezzutti, C and Anton, PA and Rohan, LC (2011) Rectal microbicides: Clinically relevant approach to the design of rectal specific placebo formulations. AIDS Research and Therapy, 8.

Published Version
Available under License : See the attached license file.

Download (390kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)


Background: The objective of this study is to identify the critical formulation parameters controlling distribution and function for the rectal administration of microbicides in humans. Four placebo formulations were designed with a wide range of hydrophilic characteristics (aqueous to lipid) and rheological properties (Newtonian, shear thinning, thermal sensitive and thixotropic). Aqueous formulations using typical polymers to control viscosity were iso-osmotic and buffered to pH 7. Lipid formulations were developed from lipid solvent/lipid gelling agent binary mixtures. Testing included pharmaceutical function and stability as well as in vitro and in vivo toxicity.Results: The aqueous fluid placebo, based on poloxamer, was fluid at room temperature, thickened and became shear thinning at 37°C. The aqueous gel placebo used carbopol as the gelling agent, was shear thinning at room temperature and showed a typical decrease in viscosity with an increase in temperature. The lipid fluid placebo, myristyl myristate in isopropyl myristate, was relatively thin and temperature independent. The lipid gel placebo, glyceryl stearate and PEG-75 stearate in caprylic/capric triglycerides, was also shear thinning at both room temperature and 37°C but with significant time dependency or thixotropy. All formulations showed no rectal irritation in rabbits and were non-toxic using an ex vivo rectal explant model.Conclusions: Four placebo formulations ranging from fluid to gel in aqueous and lipid formats with a range of rheological properties were developed, tested, scaled-up, manufactured under cGMP conditions and enrolled in a formal stability program. Clinical testing of these formulations as placebos will serve as the basis for further microbicide formulation development with drug-containing products. © 2011 Wang et al; licensee BioMed Central Ltd.


Social Networking:
Share |


Item Type: Article
Status: Published
CreatorsEmailPitt UsernameORCID
Wang, L
Schnaare, RL
Dezzutti, Ccsd13@pitt.eduCSD13
Anton, PA
Rohan, LCrohanl@pitt.eduROHANL
Centers: Other Centers, Institutes, Offices, or Units > Magee-Women's Research Institute
Date: 7 March 2011
Date Type: Publication
Journal or Publication Title: AIDS Research and Therapy
Volume: 8
DOI or Unique Handle: 10.1186/1742-6405-8-12
Schools and Programs: School of Medicine > Obstetrics, Gynecology, and Reproductive Sciences
School of Pharmacy > Pharmaceutical Sciences
Refereed: Yes
Date Deposited: 18 Nov 2016 20:36
Last Modified: 01 Mar 2019 14:55


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item